Advances in Intravesical Therapy for the Treatment of Non-Muscle Invasive Bladder Cancer (Review)

Molecular and Clinical Oncology - United Kingdom
doi 10.3892/mco.2014.314
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Spandidos Publications

Related search

Intravesical Coxsackievirus A21 Therapy for Non-Muscle Invasive Bladder Cancer

Bladder Cancer
OncologyUrology
2020English

The Role of Molecular Genetic Alterations in Sensitivity of the Adjuvant Intravesical Therapy for Non-Muscle Invasive Bladder Cancer

Onkourologiya
OncologyRadiologyUrologyNuclear MedicineNephrologyImagingSurgery
2019English

Mp65-17 Intravesical Thalidomide Boosts Bacillus Calmete-Guérin (Bcg) in Non-Muscle Invasive Bladder Cancer Treatment

Journal of Urology
Urology
2017English

Humoral Immune Factor Changes in Group of Patients With Non-Muscle Invasive Bladder Cancer Treated With Intravesical Therapy.

Journal of the faculty of medicine baghdad
2017English

The Use of Water-Soluble Mucoadhesive Gels for the Intravesical Delivery of Epirubicin to the Bladder for the Treatment of Non-Muscle-Invasive Bladder Cancer

Journal of Pharmacy and Pharmacology
PharmacologyPharmaceutical Science
2015English

Study Protocol of a Phase II Clinical Trial of Oral Metformin for the Intravesical Treatment of Non-Muscle Invasive Bladder Cancer

BMC Cancer
Cancer ResearchOncologyGenetics
2019English

Long-Term Clinical Outcomes of a Phase I Trial of Intravesical Docetaxel in the Management of Non–muscle-Invasive Bladder Cancer Refractory to Standard Intravesical Therapy

Urology
Urology
2010English

Surveillance and Treatment of Non-Muscle-Invasive Bladder Cancer in the USA

Advances in Urology
GynecologyUrologyObstetrics
2012English

Collagen Stiffness Promoted Non-Muscle-Invasive Bladder Cancer Progression to Muscle-Invasive Bladder Cancer

OncoTargets and Therapy
OncologyPharmacology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy